Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly.

Galassi A, Ciceri P, Fasulo E, Carugo S, Cianciolo G, Cozzolino M.

Drugs Aging. 2019 Jul 15. doi: 10.1007/s40266-019-00696-3. [Epub ahead of print]

PMID:
31304565
2.

The Key Role of Phosphate on Vascular Calcification.

Cozzolino M, Ciceri P, Galassi A, Mangano M, Carugo S, Capelli I, Cianciolo G.

Toxins (Basel). 2019 Apr 9;11(4). pii: E213. doi: 10.3390/toxins11040213. Review.

3.

Hyperphosphatemia: a novel risk factor for mortality in chronic kidney disease.

Cozzolino M, Ciceri P, Galassi A.

Ann Transl Med. 2019 Feb;7(3):55. doi: 10.21037/atm.2018.06.50. No abstract available.

4.

Uremic Patients with Increased Vascular Calcification Score Have Serum with High Calcific Potential: Role of Vascular Smooth Muscle Cell Osteoblastic Differentiation and Apoptosis.

Ciceri P, Galassi A, Alfieri C, Messa P, Cozzolino M.

Blood Purif. 2019 Feb 6:1-8. doi: 10.1159/000497229. [Epub ahead of print]

PMID:
30726841
5.

Vitamin K in Chronic Kidney Disease.

Cozzolino M, Mangano M, Galassi A, Ciceri P, Messa P, Nigwekar S.

Nutrients. 2019 Jan 14;11(1). pii: E168. doi: 10.3390/nu11010168. Review.

6.

Cardiovascular disease in dialysis patients.

Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A.

Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. doi: 10.1093/ndt/gfy174.

7.

The Cardiovascular Burden in End-Stage Renal Disease.

Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F.

Contrib Nephrol. 2017;191:44-57. doi: 10.1159/000479250. Epub 2017 Sep 14. Review.

PMID:
28910790
8.

Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.

Galassi A, Bellasi A, Ciceri P, Pivari F, Conte F, Cozzolino M.

Expert Rev Clin Pharmacol. 2017 Oct;10(10):1073-1084. doi: 10.1080/17512433.2017.1371011. Epub 2017 Sep 4. Review.

PMID:
28846459
9.

Phosphate in Chronic Kidney Disease Progression.

Cozzolino M, Foque D, Ciceri P, Galassi A.

Contrib Nephrol. 2017;190:71-82. doi: 10.1159/000468915. Epub 2017 May 23. Review.

PMID:
28535520
10.

Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.

Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, Cozzolino M.

J Nephrol. 2017 Oct;30(5):677-687. doi: 10.1007/s40620-017-0404-z. Epub 2017 Apr 21. Review.

PMID:
28432640
11.

Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis.

Ciceri P, Elli F, Braidotti P, Falleni M, Tosi D, Bulfamante G, Block GA, Cozzolino M.

Atherosclerosis. 2016 Nov;254:93-101. doi: 10.1016/j.atherosclerosis.2016.09.071. Epub 2016 Sep 30.

PMID:
27716569
12.

Osteonectin (SPARC) Expression in Vascular Calcification: In Vitro and Ex Vivo Studies.

Ciceri P, Elli F, Cappelletti L, Tosi D, Savi F, Bulfamante G, Cozzolino M.

Calcif Tissue Int. 2016 Nov;99(5):472-480. Epub 2016 Jun 23.

PMID:
27339669
13.

Secondary Hyperparathyroidism in End-Stage Renal Disease: No Longer a Matter for Surgeons?

Cozzolino M, Elli F, Carugo S, Ciceri P.

Blood Purif. 2016;42(1):44-8. doi: 10.1159/000445204. Epub 2016 Apr 2. Review.

PMID:
27035129
14.

A new in vitro model to delay high phosphate-induced vascular calcification progression.

Ciceri P, Elli F, Cappelletti L, Tosi D, Braidotti P, Bulfamante G, Cozzolino M.

Mol Cell Biochem. 2015 Dec;410(1-2):197-206. doi: 10.1007/s11010-015-2552-6. Epub 2015 Sep 7.

PMID:
26346159
15.

The calcimimetic calindol prevents high phosphate-induced vascular calcification by upregulating matrix GLA protein.

Ciceri P, Elli F, Brenna I, Volpi E, Brancaccio D, Cozzolino M.

Nephron Exp Nephrol. 2012;122(3-4):75-82. doi: 10.1159/000349935. Epub 2013 Mar 28.

PMID:
23548867
16.

Lanthanum prevents high phosphate-induced vascular calcification by preserving vascular smooth muscle lineage markers.

Ciceri P, Elli F, Brenna I, Volpi E, Romagnoli S, Tosi D, Braidotti P, Brancaccio D, Cozzolino M.

Calcif Tissue Int. 2013 Jun;92(6):521-30. doi: 10.1007/s00223-013-9709-7. Epub 2013 Feb 17.

PMID:
23416967
17.

Phosphate control in peritoneal dialysis.

Cozzolino M, Stucchi A, Rizzo MA, Brenna I, Elli F, Ciceri P, Bover J, Cusi D, Gallieni M.

Contrib Nephrol. 2012;178:116-123. doi: 10.1159/000337831. Epub 2012 May 25. Review.

PMID:
22652727
18.

The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification.

Ciceri P, Volpi E, Brenna I, Elli F, Borghi E, Brancaccio D, Cozzolino M.

Biochem Biophys Res Commun. 2012 Feb 24;418(4):770-3. doi: 10.1016/j.bbrc.2012.01.097. Epub 2012 Jan 28.

PMID:
22310712
19.

Vascular calcification in chronic kidney disease: a changing scenario.

Cozzolino M, Brenna I, Ciceri P, Volpi E, Cusi D, Brancaccio D.

J Nephrol. 2011 May-Jun;24 Suppl 18:S3-10. doi: 10.5301/JN.2011.7427. Review.

PMID:
21623576
20.

Restoring the physiology of vitamin D receptor activation and the concept of selectivity.

Cozzolino M, Brenna I, Volpi E, Ciceri P, Mehmeti F, Cusi D.

Contrib Nephrol. 2011;171:151-156. doi: 10.1159/000327166. Epub 2011 May 23. Review.

PMID:
21625104

Supplemental Content

Loading ...
Support Center